Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldschmidt

Showing results (381-390 of 472) with videos related to

Pageof 48
Sort By:
Frontiers in Oncology|March 25, 2024
Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology settingShirish M Gadgeel, Pragya Rai, Srinivas Annavarapu, et al.
Veterinary Pathology|November 23, 2005
Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinomaD A Heller, C A Clifford, M H Goldschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphomaR Haas, M Moos, A Karcher, et al.
Leukemia|November 20, 2013
Inherited genetic susceptibility to multiple myelomaG J Morgan, D C Johnson, N Weinhold, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 16, 2005
[Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma]K Wasser, T Moehler, S Nosas-Garcia, et al.
British Journal of Cancer|September 14, 2006
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgeryA Zahlten-Hinguranage, H Goldschmidt, F W Cremer, et al.
Leukemia|December 17, 2015
Gene signature combinations improve prognostic stratification of multiple myeloma patientsW J Chng, T-H Chung, S Kumar, et al.
Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III StudyNicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Bone Marrow Transplantation|July 15, 2009
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsS Fruehauf, G Ehninger, K Hübel, et al.
Pageof 48

Showing results (381-390 of 472) with videos related to

Sort By:
Pageof 48
Frontiers in Oncology|March 25, 2024
Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology settingShirish M Gadgeel, Pragya Rai, Srinivas Annavarapu, et al.
Veterinary Pathology|November 23, 2005
Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinomaD A Heller, C A Clifford, M H Goldschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphomaR Haas, M Moos, A Karcher, et al.
Leukemia|November 20, 2013
Inherited genetic susceptibility to multiple myelomaG J Morgan, D C Johnson, N Weinhold, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 16, 2005
[Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma]K Wasser, T Moehler, S Nosas-Garcia, et al.
British Journal of Cancer|September 14, 2006
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgeryA Zahlten-Hinguranage, H Goldschmidt, F W Cremer, et al.
Leukemia|December 17, 2015
Gene signature combinations improve prognostic stratification of multiple myeloma patientsW J Chng, T-H Chung, S Kumar, et al.
Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III StudyNicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Bone Marrow Transplantation|July 15, 2009
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsS Fruehauf, G Ehninger, K Hübel, et al.
Pageof 48